Table 2.

Percentage of patients with simulated testosterone concentrations at castration levels (<50 ng/dL) and at profound castration levels (<20 ng/dL) after temporary treatment interruptions of different durations (N = 1,000 for each scenario)

Testosterone concentration (ng/dL)	Full adherence (%)	Duration of temporary treatment interruption
		1 day (%)	2 days (%)	3 days (%)	7 days (%)	14 days (%)	21 days (%)	28 days (%)
< 50	100.0	99.9	99.4	99.3	97.3	85.5	61.2	36.5
< 20	93.8	87.9	82.3	76.2	54.4	28.2	12.4	5.6